Browsing: Europes

This week, the U.K.’s healthcare regulatory body approved Eli Lilly’s (NYSE: LLY) weight loss drug orforglipron, sold as Foundayo, for weight management and type 2 diabetes. Unlike Lilly’s other weight loss drug, Zepbound, Foundayo is a pill, not an injectable medication — and that’s a fresh piece of good news for investors

Children and adolescents in Europe are not reaching adequate levels of physical fitness in terms of strength, flexibility and body composition, a new study has found

Children and adolescents in Europe are not reaching adequate levels of physical fitness in terms of strength, flexibility and body composition, a new study has found

Greece Tops Europe’s Sedentary Lifestyle Risk Rankings as the Netherlands, Malta, Germany, and More Countries Face a Growing Health Challenge Sparking a Major Sports Tourism and Active Travel Revolution in 2026 – Travel And Tour World